Exact Sciences Email Format

Biotechnology Research
5,001-10,000 employees
Madison, WI, USA

Exact Sciences is a biotechnology company specializing in cancer screening and diagnostic testing, now part of Abbott, serving patients and healthcare providers worldwide.

Find contacts at Exact Sciences

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@exactsciences.com

Company Overview

Industry
Biotechnology Research
Founded
1995
Headquarters
Madison, WI, USA
Revenue
$2.5B-$5B
FUNDING Stage
Public
Key Executives
Kevin T. Conroy (Chairman, President and Chief Executive Officer), Philip Boudreau (Executive Vice President, Finance and Chief Financial Officer), Nassar Nizami (Chief Information Officer)

Tech Stack

AWS

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Exact Sciences?

Exact Sciences uses the firstinitiallast format on exactsciences.com, so Jane Smith would be jsmith@exactsciences.com.

What is Exact Sciences' Cologuard test and who is it designed for?

Cologuard is Exact Sciences' FDA-approved at-home stool DNA test for colorectal cancer screening. It is designed for adults at average risk for colorectal cancer and does not require any special diet or bowel prep.

How many countries is the Exact Sciences Oncotype DX test available in?

The Oncotype DX suite of genomic tests from Exact Sciences is available in more than 90 countries, helping oncologists guide treatment decisions for patients with early-stage breast and colon cancers.

Who leads Exact Sciences as its chief executive?

Kevin T. Conroy serves as Chairman, President, and Chief Executive Officer of Exact Sciences. Philip Boudreau is the company's Executive Vice President, Finance and Chief Financial Officer.

Does Exact Sciences have a hereditary cancer risk testing product?

Yes, Exact Sciences offers Riskguard through its subsidiary PreventionGenetics. Riskguard is a blood or saliva test that detects genetic mutations associated with hereditary cancer risk and became available in 2024. Tools like Clay can help you find the right Exact Sciences contact if you are building outreach around this product area.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles